Effects of the estrous cycle and ovarian hormones on central expression of interleukin-1 evoked by stress in female rats

Neuroendocrinology

Volumn 100, Issue , 2014, Pages 162-177

  Arakawa, Keiko ^a   Arakawa, Hiroyuki ^a   Hueston, Cara M ^a   Deak, Terrence ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Estrogen receptors; Neuroinflammation; Progesterone; Proinflammatory cytokines; Stress

Indexed keywords

ESTRADIOL; ESTRADIOL BENZOATE; INTERLEUKIN 1; PROGESTERONE; AGENTS ACTING ON THE GENITAL SYSTEM; ESTRADIOL 3-BENZOATE; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

ADULT; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ESTRUS CYCLE; EVOKED RESPONSE; FEMALE; FOOTSHOCK; GENE EXPRESSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; LOW DRUG DOSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STRESS; TREATMENT OUTCOME; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ELECTRIC SHOCK; IMMUNOMODULATION; MENTAL STRESS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROSHOCK; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROUS CYCLE; FEMALE; INTERLEUKIN-1; NEUROIMMUNOMODULATION; OVARIECTOMY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROGESTERONE; RATS, SPRAGUE-DAWLEY; REPRODUCTIVE CONTROL AGENTS; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84920565299     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000368606     Document Type: Article

References (117)

1. Sternberg EM, Chrousos GP, Wilder RL, Gold PW: The stress response and the regulation of inflammatory disease. Ann Intern Med 1992; 117: 854-866.
2. Calcagni E, Elenkov I: Stress system activity, innate and T helper cytokines, and susceptibility to immune-related disease. Ann NY Acad Sci 2006; 1069: 62-76.
3. Eskandari F, Sternberg EM: Neural-immune interactions in health and disease. Ann NY Acad Sci 2002; 966: 20-27.
4. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005; 12: 255-269.
5. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994; 15: 74-80.
6. Bamberger ME, Landreth GE: Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist 2002; 8: 276-283.
7. McGeer EG, McGeer PL: Inflammatory processes in Alzheimer's diesase. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 741-749.
8. O'Brien SM, Scully P, Scott LV, Dinan TG: Cytokine profiles in bipolar affective disorder: focus on actually ill patients. J Affect Disord 2006; 90: 263-267.
9. Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M: The cyclooxygenase-2 inhibitor celevoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006; 11: 680-684.
10. Muller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K: Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 2002; 159: 1029-1034.
11. in 't Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH: Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001; 345: 1515-1521.
12. Morale MC, Serra PA, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B: Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 2006; 138: 869-878.
13. Roof RL, Hall ED: Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000; 17: 367-388.
14. Ossewaarde L, Hermans EJ, van Wingen GA, Kooijman SC, Johansson I, Backstrom T, Fernandez G: Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle. Psychoneuroendocrinology 2009; 35: 47-55.
15. Cannon JG, Dinarello CA: Increased plasma interleukin-1 activity in women after ovulation. Science 1985; 227: 1247-1249.
16. Cannon JG, St Pierre BA: Gender differences in host defense mechanisms. J Psychiatr Res 1997; 31: 99-113.
17. Giron-Gonzalez JA, Moral FJ, Elvira J, Garcia-Gil D, Guerrero F, Gavilan I, Escober L: Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000; 143: 31-36.
18. Northoff H, Symons S, Zieker D, Schaible EV, Schafer K, Thoma S, Loffler M, Abbasi A, Simon P, Niess AM, Fehrenbach E: Gender-And menstrual phase dependent regulation of inflammatory gene expression in response to aerobic exercise. Exerc Immunol Rev 2008; 14: 86-103.
19. Aschner M: Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol Lett 1998; 102/103: 283-287.
20. Skaper SD: The brain as a target for inflammatory processes and neuroprotective strategies. Ann NY Acad Sci 2007; 1122: 23-34.
21. Blandino P Jr., Barnum CJ, Deak T: The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress. J Neuroimmunol 2006; 173: 87-95.
22. Swanson LW, Sawchenko PE: Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 1980; 31: 410-417.
23. Blandino P Jr., Barnum CJ, Solomon LG, Larish Y, Lankow BS, Deak T: Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav Immun 2009; 23: 958-968.
24. Spulber S, Schultzberg M: Connection between inflammatory processes and transmitter function-modulatory effects of interleukin-1. Prog Neurobiol 2009; 90: 256-262.
25. Rothwell NJ, Luheshi GN: Interleukin-1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000; 23: 618-625.
26. Basu A, Krady JK, Levison SW: Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 2004; 78: 151-156.
27. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA: Interleukin-1 induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 1989; 84: 228-235.
28. Arakawa H, Blandino P Jr., Deak T: Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure. Physiol Behav 2009; 98: 139-146.
29. Ashdown H, Poole S, Boksa P, Luheshi GN: Interleukin-1 receptor antagonist as a modulator of gender differences in the febrile response to lipopolysaccharide in rats. Am J Physiol Regul Integr Comp Physiol 2007; 292:R1667-R1674.
30. Murakami N, Ono T: Sex-related differences in fever development of rats. Am J Physiol 1987; 262:R284-R289.
31. Rivier C: Stimulatory effect of interleukin-1 on the hypothalamic-pituitary-Adrenal axis of the rat: influence of age, gender and circulating steroids. J Endocrionol 1994; 140: 365-372.
32. Avitsur R, Donchin O, Barak O, Cohen E, Yirmiya R: Behavioral effects of interleukin-1beta: modulation by gender, estrus cycle, and progesterone. Brain Behav Immun 1995; 9: 234-241.
33. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A: Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 27: 1809-1818.
34. Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A: The endogeneous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006; 147: 2263-2272.
35. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986; 320: 134-139.
36. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996; 93: 5925-5930.
37. Shughrue PJ, Lane MV, Merchenthaler I: Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study. Endocrinology 1997; 138: 5476-5484.
38. Shughrue PJ, Lane MV, Merchenthaier I: Comparative distribution of estrogen receptor-Alpha and-beta mRNA in the rat central nervous system. J Comp Neurol 1997; 388: 507-525.
39. Pluchino N, Cubeddu A, Giannini A, Merlini S, Cela V, Angioni S, Genazzani AR: Progestogens and brain: an update. Maturitas 2009; 62: 349-355.
40. Hueston CM, Barnum CJ, Eberle JA, Ferraioli FJ, Buck HM, Deak T: Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat. Physiol Behav 2011; 104: 187-198.
41. Viau V, Meaney MJ: Variations in the hypothalamic-pituitary-Adrenal response to stress during the estrous cycle in the rat. Endocrinology 1991; 129: 2503-2511.
42. Donadio MV, Kunrath A, Corezola KL, Franci CR, Anselmo-Franci JA, Lucion AB, Sanvitto GL: Effects of acute stress on the day of proestrus on sexual behavior and ovulation in female rats: participation of the angiotensinergic system. Physiol Behav 2007; 92: 591-600.
43. Monies GS, Luque EH: Effects of ovarian steroids on vaginal smears in the rat. Acta Anat 1988; 133: 192-199.
44. Kopp C, Ressel V, Wigger E, Tobler I: Influence of estrus cycle and ageing on activity patterns in two inbred mouse strains. Behav Brain Res 2006; 167: 165-174.
45. Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW: The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 1999; 140: 79-86.
46. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego, Academic Press, 1998.
47. Leuner B, Mendolia-Loffredo S, Shors TJ: High levels of estrogen enhance associative memory formation in ovariectomized females. Psychoneuroendocrinology 2004; 29: 883-890.
48. Frye CA, Rhodes ME: Enhancing effects of estrogen on inhibitory avoidance performance may be in part independent of intracellular estrogen receptors in the hippocampus. Brain Res 2002; 956: 285-293.
49. Butcher RL, Collins WE, Fugo NW: Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17? throughout the 4-day estrous cycle of the rat. Endocrinology 1973; 94: 1704-1708.
50. Drury RA, Gold RM: Differential effects of ovarian hormones on reactivity to electric footshock in the rat. Physiol Behav 1978; 20: 187-191.
51. Ter Horst GJ, Wichmann R, Gerrits M, Westenbroek C, Lin Y: Sex differences in stressresponses: focus on ovarian hormones. Physiol Behav 2009; 97: 239-249.
52. Dosiou C, Lathi RB, Tulac S, Huang ST, Giudice LC: Interferon-related and other immune genes are downregulated in peripheral blood leukocytes in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 2004; 89: 2501-2504.
53. Weinberg A, Enomoto L, Marcus R, Canniff J: Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation. J Reprod Immunol 2011; 89: 70-77.
54. Laflamme N, Nappi RE, Droiet G, Labrie C, Rivest S: Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain. anatomical evidence of distinct roles of each subtype. J Neurobiol 1998; 36: 357-378.
55. Alves SE, Lopez V, McEwen BS, Weiland NG: Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc Natl Acad Sci U S A 1998; 95: 3281-3286.
56. Somponpun SJ, Sladek CD: Depletion of oestrogen receptor-beta expression in magnocellular arginine vasopressin neurons by hypovolaemia and dehydration. J Neuroendocrinol 2004; 16: 544-549.
57. Suzuki S, Handa RJ: Estrogen receptor-beta, but not estrogen receptor-Alpha, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J Comp Neurol 2005; 484: 28-42.
58. Estacio MAC, Yamada S, Tsukamura H, Hirunagi K, Maeda K: Effect of fasting and immobilization stress on estrogen receptor immunoreactivity in the brain in ovariectomized female rats. Brain Res 1996; 717: 55-61.
59. Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ: Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 2003; 121: 837-845.
60. LaMarca BD, Chandler DL, Grubbs L, Bain J, McLemore GR Jr., Granger JP, Ryan MJ: Role of sex steroids in modulating tumor necrosis factor alpha-induced changes in vascular function and blood pressure. Am J Hypertens 2007; 20: 1216-1221.
61. Prisby RD, Dominguez JM 2nd, Muller-Delp J, Allen MR, Delp MD: Aging and estrogen status: a possible endothelium-dependent vascular coupling mechanism in bone remodeling. PLoS One 2012; 7:e48564.
62. Schenkel PC, Fernandes RO, Viegas VU, Campos C, Fernandes TRG, da Rosa Araujo AS, Bello-Klein A: Catalase influence in the regulation of coronary resistance by estrogen: joint action of nitric oxide and hydrogen peroxide. Oxid Med Cell Longev 2014; 2014: 159852.
63. Simpson ER: Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003; 86: 225-230.
64. Nelson LR, Bulun SE: Estrogen production and action. J Am Acad Dermatol 2001; 45: S116-S124.
65. Budec M, Koko C, Miloanovic TLB, Petkovic A: Acute ethanol treatment increases level of progesterone in ovariectomized rats. Alcohol 2002; 26: 173-178.
66. Schaeffer C, Aron C: Stress-related effects on the secretion of progesterone by the adrenals in castrated male rats presented to stimulus males. Involvement of oestrogen. Acta Endocrinol (Copenh) 1987; 114: 440-445.
67. Romeo RD, Bellani R, McEwen BS: Stress-induced progesterone secretion and progesterone receptor immunoreactivity in the paraventricular nucleus are mediated by pubertal development in male rats. Stress 2005; 8: 265-271.
68. Fajer AB, Holzbauer M, Newport HM: The contribution of the adrenal gland to the total amount of progesterone produced in the female rat. J Physiol 1971; 214: 115-126.
69. Kalil B, leite CM, Carvalho-lima M, Anselmo-Franci JA: Role of sex steroids in progesterone and corticosterone response to acute restraint stress in rats: sex differences. Stress 2013; 16: 452-460.
70. Traslavina GA, Franci CR: The CRH-R 1 receptor mediates luteinizing hormone, prolactin, corticosterone and progesterone secretion induced by restraint stress in estrogenprimed rats. Brain Res 2011; 1421: 11-19.
71. Figueirodo HF, Dolgas CM, Herman JP: Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology 2002; 143: 2534-2540.
72. Gerrits M, Grootkarijin A, Bekkering BF, Bruinsma M, Den Boer JA, Ter horst GJ: Cyclic estradiol replacement attenuates stress-induced c-fos expression in the PVN of ovariectomized rats. Brain Res Bull 2005; 67: 147-155.
73. Ochedalski T, Subburaju S, Wynn PC, Aguilera G: Interaction between oestrogen and oxytocin on hypothalamic-pituitary-Adrenal axis activity. J Neuroendocrinol 2007; 19: 189-197.
74. Chin J, Sternin O, Wu HBK, Burrell S, Lu D, Jenab S, Perrotti LI, Quinones-Jenab V: Endogenous gonadal hormones modulate behavioral and neurochemical responses to acute and chronic cocaine administration. Brain Res 2002; 945: 123-130.
75. Suzuki S, Solberg LC, Redei EE, Handa RJ: Prepro-thyrotropin releasing hormone 178-199 immunoreactivity is altered in the hypothalamus of the Wistar-Kyoto strain of rat. Brain Res 2001; 913: 224-233.
76. Walker QD, Cabassa J, Hilmar AS, Kuhn CM: Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology 2001; 25: 118-130.
77. Walker QD, Frances R, Cabbassa J, Kuhn CM: Effect of ovarian hormones and estrous cycle on stimulation of the hypothalamo-pituitaryadrenal axis by cocaine. J Pharmacol Exp Ther 2001; 297: 291-298.
78. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP: Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000; 141: 3646-3656.
79. Harris HA: Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 2007; 21: 1-13.
80. Lewis DK, Johnson AB, Stohlgren S, Harms A, Sohrabji F: Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-Aged female rats. J Neuroimmunol 2008; 195: 47-59.
81. Reyes BAS, Tsukamura H, I'Anson H, Estacio MA, Hirunagi K, Maeda K: Temporal expression of estrogen receptor alpha in the hypothalamus and medulla oblongata during fasting: a role of noradrenergic neurons. J Endocrinol 2006; 190: 593-600.
82. Ruh MF, Bi Y, Cox L, Berk D, Howlett AC, Bellone CJ: Effect of environmental estrogens on IL-1beta promoter activity in a macrophage cell line. Endocrine 1998; 9: 207-211.
83. Ruh MF, Bi Y, D'Alonzo R, Bellone CJ: Effect of estrogens on IL-1beta promoter activity. J Steroid Biochem Mol Biol 1988; 66: 203-210.
84. Prange-Kiel J, Wehrenberg U, Jarry H, Rune GM: Para/autocrine regulation of estrogen receptors in hippocampal neurons. Hippocampus 2003; 13: 226-234.
85. Osterlund M, Kuiper GGJM, Gustafsson JA, Hurd YL: Differential distribution and regulation of estrogen receptor-Alpha and-beta mRNA within the female rat brain. Brain Res Mol Brain Res 1998; 54: 175-180.
86. Patisaul HB, Whitten PL, Young LJ: Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol. Brain Res Mol Brain Res 1999; 67: 165-171.
87. Suzuki S, Handa RJ: Regulation of estrogen receptor-beta expression in the female rat hypothalamus: differential effects of dexamethasone and estradiol. Endocrinology 2004; 145: 3658-3670.
88. Lauber AH, Mobbs CV, Muramatsu M, Pfaff DW: Estrogen receptor messenger RNA expression in rat hypothalamus as a function of genetic sex and estrogen dose. Endocrinology 1991; 129: 3180-3186.
89. Lauber AH, Romano GJ, Mobbs CV, Pfaff DW: Estradiol regulation of estrogen receptor messenger ribonucleic acid in rat mediobasal hypothalamus: an in situ hybridization study. J Neuroendcrinol 1991; 2: 605-611.
90. Greco B, Allegretto EA, Tetel MJ, Blaustein JD: Coexpression of ERbeta with ERalpha and progestin receptor proteins in the female rat forebrain: effects of estradiol treatment. Endocrinology 2001; 142: 5172-5181.
91. Wagner CK, Pfau JL, De Vries GJ, Merchenthaler IJ: Sex difference in progesterone receptor immunoreactivity in neonatal mouse brain depend on estrogen receptor alpha expression. J Neurobiol 2001; 47: 176-182.
92. Shughrue PJ, Dellovade TL, Merchenthaler I: Estrogen modulates oxytocin gene expression in regions of the rat supraoptic and paraventricular nuclei that contain estrogen receptorbeta. Prog Brain Res 2002; 139: 15-29.
93. Amico JA, Thomas A, Hollingshead DJ: The duration of estradiol and progesterone exposure prior to progesterone withdrawal regulates oxytocin mRNA levels in the paraventricular nucleus of the rat. Endocr Res 1997; 23: 141-156.
94. Kudwa AE, Rissman EF: Double oestrogen receptor alpha and beta knockout mice reveal differences in neural oestrogen-mediated progestin receptor induction and female sexual behaviour. J Neuroendocrinol 2003; 15: 978-983.
95. Moguilewsky M, Raynaud JP: Estrogen-sensitive progestin-binding sites in the female rat brain and pituitary. Brain Res 1979; 164: 165-175.
96. Funabashi T, Kleopoulos SP, Brooks PH, Kimura F, Pfaff DW, Shinohara K, Mobbs CV: Changes in estrogenic regulation of estrogen receptor alpha mRNA and progesterone receptor mRNA in the female rat hypothalamus during aging: an in situ hybridization study. Neurosci Res 2000; 38: 85-92.
97. Lauber AH, Romano GJ, Pfaff DW: Sex difference in estradiol regulation of progestin receptor mRNA in rat mediobasal hypothalamus as demonstrated by in situ hybridization. Neuroendocrinology 1991; 53: 608-613.
98. Romano GJ, Krust A, Pfaff DW: Expression and estrogen regulation of progesterone receptor mRNA in neurons of the mediobasal hypothalamus: an in situ hybridization study. Mol Endocrinol 1989; 3: 1295-1300.
99. Blaustein JD, Turcotte J: Estradiol-induced progestin receptor immunoreactivity is found only in estrogen receptor-immunoreactive cells in guinea pig brain. Neuroendocrinology 1989; 49: 454-461.
100. Warembourg M, Jolivet A, Milgrom E: Immunohistochemical evidence of the presence of estrogen and progesterone receptors in the same neurons of the guinea pig hypothalamus and preoptic area. Brain Res 1989; 480: 1-15.
101. Kudwa AE, Gustafsson JA, Rissman EF: Estrogen receptor beta modulates estradiol induction of progestin receptor immunoreactivity in male, but not in female, mouse medial preoptic area. Endocrinology 2004; 145: 4500-4506.
102. Andersen ML, Bignotto M, Machado RB, Tufik S: Different stress modalities result in distinct steroid hormone responses by male rats. Braz J Med Biol Res 2004; 37: 791-797.
103. Boehm N, Plas-Roser S, Aron C: Does prolactin control the blood progesterone level on early diestrus in rats? Experientia 1982; 38: 1253-1254.
104. John W, Funder MD: Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 1997; 48: 231-240.
105. De Kloet ER, Oitzl MS, Schobitz B: Cytokines and the brain corticosteroid receptor balance: relevance to pathophysiology of neuroendocrine-immune communication. Psychoneuroendocrinology 1994; 19: 121-134.
106. Buckingham JC, Loxley HD, Taylor AD, Flower RJ: Cytokines, glucocorticoids and neuroendocrine function. Pharmacol Res 1994; 30: 35-42.
107. Miller L, Hunt JS: Regulation of TNF-? production in activated mouse macrophages by progesterone. J Immunol 1998; 160: 5098-5104.
108. Brown TJ, MacLusky NJ, Shanabrough M, Naftolin F: Comparison of age-And sex-related changes in cell nuclear estrogen-binding capacity and progestin receptor induction in the rat brain. Endocrinology 1990; 126: 2965-2972.
109. Zhang Z, Yang R, Zhou R, Li L, Sokabe M, Chen L: Progesterone promotes the survival of newborn neurons in the dentate gyrus of adult male mice. Hippocampus 2010; 20: 402-412.
110. Zhang Z, Yang R, Cai W, Bai Y, Sokabe M, Chen L: Treatment with progesterone after focal cerebral ischemia suppresses proliferation of progenitor cells but enhances survival of newborn neurons in adult male mice. Neuropharmacology 2010; 58: 930-939.
111. Goodman Y, Bruce AJ, Cheng B, Mattson MP: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66: 1836-1844.
112. Pettus EH, Wright DW, Stein DG, Hoffman SW: Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005; 1049: 112-119.
113. Sayeed I, Stein DG: Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res 2009; 175: 219-237.
114. Hurwitz A, Ricciarelli E, Botero L, Rohan RM, Hernandez ER, Adashi E: Endocrineand autocrine-mediated regulation of rat ovarian (theca-interstitial) interleukin-1beta gene expression: gonadotropin-dependent preovulatory acquisition. Endocrinology 1991; 129: 3427-3429.
115. Srivastava S, Toraldo G, Weitzmann MN, Genci S, Ross FP, Pacifici R: Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kB ligand (RANKL)-induced JNK activation. J Biol Chem 2001; 276: 8836-8840.
116. Arakawa H, Cruz S, Deak T: Attractiveness of illness-Associated odorant cues in female rats is modulated by ovarian hormones, but not associated with pro-inflammatory cytokine levels. Brain Behav Immun 2012; 26: 40-49.
117. Hueston CM, Deak T: On the time course, generality and regulation of plasma progesterone release in male rats by stress exposure. Endocrinology 2014; 155: 3527-3537.